Syngene Expands Global Footprint with $50M US Facility Acquisition

Syngene International has acquired its first US manufacturing facility for approximately USD 50 million. The acquisition aims to enhance service capabilities in human and animal health markets. Expected to finalize by March 2025, the investment includes purchasing and operational setup costs.

Syngene International announced on Monday its acquisition of a US manufacturing facility for about USD 50 million.

The facility was purchased by Syngene USA Inc, a wholly-owned subsidiary, from Emergent Manufacturing Operations Baltimore, LLC.

This purchase aims to improve service offerings in both human and animal health sectors. The total investment comprises USD 36.5 million for the acquisition and additional expenses to operationalize the site. The completion of this acquisition is anticipated by March 2025, pending customary closing conditions.

(With inputs from agencies.)